Yanyang Nan

607 total citations
26 papers, 434 citations indexed

About

Yanyang Nan is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yanyang Nan has authored 26 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Yanyang Nan's work include Immune Cell Function and Interaction (7 papers), Phagocytosis and Immune Regulation (7 papers) and Autophagy in Disease and Therapy (5 papers). Yanyang Nan is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Phagocytosis and Immune Regulation (7 papers) and Autophagy in Disease and Therapy (5 papers). Yanyang Nan collaborates with scholars based in China, United States and United Kingdom. Yanyang Nan's co-authors include Dianwen Ju, Xuyao Zhang, Jiajun Fan, Jingyun Luan, Wei Chen, Yichen Wang, Guangxun Meng, Shaofei Wang, Wenjing Xue and Caili Xu and has published in prestigious journals such as Biomaterials, International Journal of Molecular Sciences and Nanoscale.

In The Last Decade

Yanyang Nan

24 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanyang Nan China	12	147	129	76	64	57	26	434
Caixia Lin China	12	171 1.2×	76 0.6×	60 0.8×	44 0.7×	51 0.9×	17	473
Amit Laskar Sweden	8	112 0.8×	88 0.7×	79 1.0×	60 0.9×	74 1.3×	11	390
Howon Seo South Korea	12	193 1.3×	146 1.1×	62 0.8×	89 1.4×	110 1.9×	18	565
Xue Song China	13	201 1.4×	83 0.6×	45 0.6×	54 0.8×	127 2.2×	52	519
Jiaming Guo China	14	182 1.2×	80 0.6×	62 0.8×	44 0.7×	87 1.5×	29	506
Xiaobo Wang China	13	200 1.4×	54 0.4×	94 1.2×	34 0.5×	99 1.7×	42	534
Qing Guo China	14	205 1.4×	172 1.3×	76 1.0×	32 0.5×	38 0.7×	30	570
Lixia Zheng China	13	208 1.4×	45 0.3×	65 0.9×	40 0.6×	49 0.9×	30	451
Yanfang Wang China	17	174 1.2×	98 0.8×	176 2.3×	41 0.6×	91 1.6×	31	577

Countries citing papers authored by Yanyang Nan

Since Specialization

Citations

This map shows the geographic impact of Yanyang Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyang Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyang Nan more than expected).

Fields of papers citing papers by Yanyang Nan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanyang Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyang Nan. The network helps show where Yanyang Nan may publish in the future.

Co-authorship network of co-authors of Yanyang Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Yanyang Nan. A scholar is included among the top collaborators of Yanyang Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyang Nan. Yanyang Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yuting, Hanqi Wang, Caili Xu, et al.. (2025). Rubicon siRNA-encapsulated liver-targeting nanoliposome is a promising therapeutic for non-alcoholic fatty liver disease. International Journal of Pharmaceutics. 672. 125291–125291.

Nan, Yanyang, Qian Wang, Xiaoxue Du, et al.. (2025). Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models. Molecular Therapy. 33(10). 4988–5002. 14 indexed citations

Wang, Yichen, Yanyang Nan, Chunguang Ma, et al.. (2024). A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE. Cell Death and Disease. 15(4). 293–293. 9 indexed citations

Xu, Caili, Xiting Huang, Qinchao Hu, et al.. (2024). Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer. Biomedicine & Pharmacotherapy. 180. 117550–117550. 38 indexed citations

Nan, Yanyang, Yuting Zhang, Jiajun Fan, et al.. (2024). Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation. Pharmacological Research. 210. 107486–107486. 2 indexed citations

Huang, Xiting, Qian Wang, Yanyang Nan, et al.. (2024). Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer. Biomedicines. 12(9). 2152–2152.

Nan, Yanyang, Yu Bai, Tao Wu, et al.. (2024). Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy. Journal for ImmunoTherapy of Cancer. 12(9). e009236–e009236. 9 indexed citations

Xue, Wenjing, Caili Xu, Kaiqi Zhang, et al.. (2024). Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer. Cell Death Discovery. 10(1). 393–393. 32 indexed citations

Zhang, Yuxia, Wenjing Xue, Caili Xu, et al.. (2023). Innate Immunity in Cancer Biology and Therapy. International Journal of Molecular Sciences. 24(14). 11233–11233. 11 indexed citations

10.

Cao, Zhonglian, Hui Zhao, Jiajun Fan, et al.. (2023). Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response. Cell Death Discovery. 9(1). 8–8. 16 indexed citations

11.

Nan, Yanyang, Xuyao Zhang, Shaofei Wang, et al.. (2023). Targeting CD47 Enhanced the Antitumor Immunity of PD-L1 Blockade in B-Cell Lymphoma. Immunotherapy. 15(3). 175–187. 3 indexed citations

12.

Zhang, Yuting, et al.. (2023). Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosis. Cell Death and Disease. 14(11). 740–740. 11 indexed citations

13.

Lin, Jun, Dan Liu, Zhen Gao, et al.. (2022). Characterization of light chain c-terminal extension sequence variant in one bispecific antibody. Frontiers in Chemistry. 10. 994472–994472. 1 indexed citations

14.

Zhang, Xuyao, Caili Xu, Yanyang Nan, et al.. (2022). Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma. Frontiers in Immunology. 13. 1004475–1004475. 3 indexed citations

15.

Ma, Qianqian, Fangyu Liu, Zhonglian Cao, et al.. (2022). A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice. Frontiers in Immunology. 13. 1011442–1011442. 5 indexed citations

16.

Fan, Jiajun, Qianqian Ma, Lei Han, et al.. (2022). A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease. Journal of Nanobiotechnology. 20(1). 237–237. 12 indexed citations

17.

Nan, Yanyang, Chang Liu, Guangyu Lin, et al.. (2020). Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 20(13). 1592–1603. 4 indexed citations

18.

Liu, Chang, Yanyang Nan, Cheng Chen, et al.. (2020). Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy. Bioorganic & Medicinal Chemistry Letters. 30(8). 127038–127038. 13 indexed citations

19.

Zhang, Xuyao, Wei Chen, Jiajun Fan, et al.. (2018). Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma. Carcinogenesis. 39(5). 689–699. 54 indexed citations

20.

Wang, Yichen, Xuyao Zhang, Jiajun Fan, et al.. (2018). Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E. Frontiers in Immunology. 9. 1799–1799. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact